In the News

New vaccine being studied for HPV-positive head and neck cancers

4/17/2024

Researchers at Providence Cancer Institute are exploring a range of innovative approaches to targeting human papillomavirus-positive head and neck squamous cell cancer.

Looking ahead: Growth and advancements in surgical oncology at Providence Cancer Institute

4/3/2024

Growing the surgical oncology programs at Providence Cancer Institute is a testament to our commitment to providing research-focused, comprehensive services and improving outcomes for patients.

Celebrating our oncology social workers

3/25/2024

In recognition of National Social Work Month, Darlene Corral, LCSW, shares a little insight into the importance of oncology social workers.

Talking to an expert: The crucial role of nutrition in cancer care

3/19/2024

In honor of National Nutrition Month® Alyssa George, MA, RDN, program manager at Oncology Nutrition, Providence Cancer Institute, talks about the important connection between cancer and nutrition.

How promoting apoptosis in new study may help people with cancer

3/21/2024

In a new clinical trial open at Providence Cancer Institute, the therapy IGM-8444 aims to promote apoptosis, potentially slowing down the growth of DR5-positive tumor cells.

Dose-escalation studies aspire to fill gaps in cancer treatment options

2/26/2024

Two early phase trials available at Providence Cancer Institute to evaluate escalating doses of different potential cancer treatments in patients with advanced solid tumors.

FDA approves cellular therapy, offering hope to more people with cancer

3/6/2024

The Food and Drug Administration has approved an adoptive cell therapy for adult patients with melanoma that has spread to other parts of the body (metastatic).

Providence oncology nurse practitioner receives Values in Action Award

2/12/2024

Jamie Zilverberg, MSN, FNP, AOCNP, receives the prestigious 2024 Values in Action Award, the highest honor given at Providence St. Joseph Health.

Celebrating Women in Science

2/9/2024

In honor of International Day of Women and Girls in Science we highlight a researcher at Earle A. Chiles Research Institute, the research arm of Providence Cancer Institute.

Virtual education: Food and common cancer myths

3/14/2024

Providence registered dietitian Christina Speaks, MS, RDN, LD, shares valuable information about food and common cancer myths.

Studies address need for more treatment options in endometrial cancer and AML

1/24/2024

New study evaluates immunotherapy in combination with other medications in people with endometrial cancer, and a phase I trial for people with AML assesses a non-engineered natural killer cell therapy

Documentary film features Providence patients, researchers in pursuit of revolutionary cancer therapy

1/10/2024

"Within Reach: The Fight to Finish Cancer" follows patient participants and teams of researchers and clinicians at Providence Cancer Institute working to create a living drug for incurable cancers.

Promising results of amivantamab studies appear in high-profile journals

3/13/2024

New articles co-authored by Dr. Rachel Sanborn feature amivantamab studies for people with NSCLC.

A remarkable year of engagement and advancements at Providence Cancer Institute

1/10/2024

Highlights from 2023 events, achievements and advancements at Providence Cancer Institute.

Meet Dr. Anderson: At home in Hood River, on a trail, beach or mountaintop

12/13/2023

Providence hematology oncologist and outdoors enthusiast Eric C. Anderson, M.D., shares his love of the Pacific Northwest and his philosophy of care for patients.

Immunotherapies for GI and lung cancers evaluated in new studies

11/20/2023

A study for people with GI cancers and two studies for people with advanced and early-stage lung cancer hope to develop better treatment options with the help of immunotherapy.

Genomic testing can improve outcomes for people with advanced cancer, study shows

11/3/2023

Providence researchers say comprehensive genomic profiling can be pivotal in identifying gene mutations in a patient and tailoring personalized treatment strategies.

Providence researchers contribute to 21 studies at SITC2023

11/20/2023

SITC 2023 provides a glimpse into scientific advances and breakthroughs in cancer immunotherapy by researchers from around the world.

Watch a free virtual talk on lung cancer prevention and treatment

Providence Cancer Institute lung cancer expert to present a virtual education talk on lung cancer screening, prevention and latest treatments.

New studies address unmet needs in treating triple-negative breast cancer

10/12/2023

Two new studies available at Earle A. Chiles Research Institute, at division of Providence Cancer Institute of Oregon, to evaluate new treatments for triple-negative breast cancer.

Dr. Urba receives award for his contributions to science and community

10/4/2023

Providence Cancer Institute of Oregon, and research director, Earle A. Chiles Research Institute, Walter J. Urba, M.D., Ph.D., receives award for his contributions to science and community.

Recognizing the important contributions of oncology APPs

2/21/2024

Providence Cancer Institute celebrates Advanced Practice Providers Week from September 25 to 29 and recognizes their important contributions more than 25 clinics and programs.

New division director and deputy director of Hematology and Medical Oncology share a vision

9/22/2023

Providence Cancer Institute of Oregon announces new division director and deputy director of Hematology and Medical Oncology.

New study aims to fill treatment gap for patients with endometrial cancer

9/18/2023

For Gynecologic Cancer Awareness Month, Providence Cancer Institute highlights a clinical trial that evaluates the safety and effectiveness of a new oral treatment for grade 1 endometrial cancer.

Two trials evaluate new approaches to treating non-Hodgkin and follicular lymphomas

8/18/2023

New trial open at Earle A. Chiles Research Institute, a division of Providence Cancer Institute of Oregon, is enrolling patients with advanced or metastatic solid tumors or non-Hodgkin lymphoma.

Two new trials enrolling patients with rectal cancer and solid tumors

7/10/2023

A phase II trial tests FOLFOX or CAPOX versus FOLFIRINOX in patients with locally advanced rectal cancer, and a phase I trial evaluates TBio-4101 in patients with advanced solid tumors.

Promising results of Providence-sponsored trial published in npj Breast Cancer

7/3/2023

Final outcomes from a Providence Cancer Institute-sponsored phase Ib trial evaluating pembrolizumab with either weekly paclitaxel or flat-dose capecitabine in treating patients with metastatic TNBC.

Providence researchers contribute to more than 20 studies presented at ASCO Annual Meeting

6/28/2023

Researchers from Earle A. Chiles Research Institute, a division of Providence Cancer Institute of Oregon, shared their investigations to advance cancer research and treatments at the premier event.

Breast cancer survivor, artist gives back to Providence

8/16/2023

Portland painter credits the support of Providence providers and creating art for helping her recover and heal from breast cancer and the loss of her mother.

Providence cancer experts offer free educational talks

9/26/2023

Virtual talks at Providence highlight MRI-guided radiation therapy for treating breast cancer, pancreatic cancer treatments, and sexual health during and after ovarian cancer.